Oct. 16, 2020 — Pfizer will not apply for emergency authorization of its coronavirus vaccine earlier than the third week in November, the corporate’s chief government mentioned in an announcement posted to Pfizer’s web site on Friday.

The reversal from the corporate’s earlier claims that it could apply for the approval in October is a blow to U.S. President Donald Trump, who repeatedly mentioned {that a} vaccine can be obtainable earlier than Election Day on Nov. 3, The New York Instances reported.

Regardless that Pfizer might have preliminary information in regards to the vaccine‘s effectiveness by the top of October, gathering security and manufacturing information would take till no less than the third week of November, Dr. Albert Bourla mentioned within the assertion.

Pfizer’s announcement was welcomed by some scientists.

“That is good, actually good,” Dr. Eric Topol, a scientific trial professional at Scripps Analysis in San Diego, advised The Instances. He was one among 60 public well being officers and different medical consultants who despatched a letter to Pfizer urging it to not rush its vaccine, The Instances reported.

Pfizer is one among 4 firms with a coronavirus vaccine in late-stage scientific trials in the US. The others are Moderna, AstraZeneca and Johnson & Johnson. Pfizer has given probably the most optimistic timeline, whereas the opposite three have mentioned later this 12 months is extra seemingly.



WebMD Information from HealthDay



Copyright © 2013-2020 HealthDay. All rights reserved.

LEAVE A REPLY

Please enter your comment!
Please enter your name here